This year, staying ahead of agricultural innovation is more critical than ever. Biotech Updates offers enhanced subscription plans designed to provide researchers, policymakers, and industry leaders with unparalleled insights and data-driven analysis.

In February 2026, we will officially release the latest ISAAA report—Global Status of Commercialized GM/Biotech Crops: 2024. Since 1996, this ISAAA report has been the world’s most authoritative source for agricultural biotechnology data. Under the leadership of Dr. Clive James, Dr. Randy Hautea, and Dr. Rhodora Romero-Aldemita, these reports have guided global policy and industry investment for decades.

Upgrade Your Access for 2026

To provide deeper value to our community, Biotech Updates is introducing new subscription plans, including access to the ISAAA report. By upgrading today, you ensure that the ISAAA report is delivered directly to your inbox on its release date.

Regular	Premium	Elite
Free	USD50/year	USD100/year
Weekly Biotech Updates Weekly Science Speaks blog Monthly Gene Editing Supplement	Weekly Biotech Updates Weekly Science Speaks blog Monthly Gene Editing Supplement ISAAA Brief 57. Global Status of Commercialized GM/Biotech Crops: 2024 (to be released in February 2026)	Weekly Biotech Updates Weekly Science Speaks blog Monthly Gene Editing Supplement ISAAA Brief 57. Global Status of Commercialized GM/Biotech Crops: 2024 (to be released in February 2026) Regional GM/biotech crop adoption reports and analysis (to be released quarterly)
Sign up	Subscribe	Subscribe

 

Early Bird Exclusive

Upgrade to the Elite Plan before January 31, 2026, and receive an additional benefit: access to Brief 57 slides (valued at US$35).

Corporate and Institutional Access

Looking to equip your entire department or research team? We offer corporate subscription packages designed for larger organizations. Contact us at knowledgecenter@isaaa.org for more details.